interventional neurology

Milpitas, California, August 4, 2026 Galaxy Therapeutics has announced that its SEAL™ Embolization System has received CE Mark certification...

ALAMEDA, California, July 22, 2026 Penumbra, Inc. has announced positive results from the THUNDER Investigational Device Exemption (IDE) study,...

SEATTLE & YOKNEAM, Israel, July 21, 2026 Rapid Medical announced U.S. Food and Drug Administration (FDA) clearance of DRIVEWIRE™...

BEVERLY, Mass., July 7, 2026 Akston Biosciences Corporation has announced encouraging preclinical data demonstrating that its investigational NGF-targeting Ambifect®...

ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...

Lake Forest, California, USA – April 22, 2026 In a significant advancement for neurovascular intervention technology, Sonorous Neurovascular has...